Literature DB >> 30147013

Molecular Mechanisms Underlying the Functions of Cellular Markers Associated with the Phenotype of Cancer Stem Cells.

Eduardo Alvarado-Ortiz1,2, Miguel Á Sarabia-Sánchez2,3, Alejandro García-Carrancá2.   

Abstract

Cancer Stem Cells (CSC) generally constitute a minor cellular population within tumors that exhibits some capacities of normal Stem Cells (SC). The existence of CSC, able to self-renew and differentiate, influences central aspects of tumor biology, in part because they can continue tumor growth, give rise to metastasis, and acquire drug and radioresistance, which open new avenues for therapeutics. It is well known that SC constantly interacts with their niche, which includes mesenchymal cells, extracellular ligands, and the Extra Cellular Matrix (ECM). These interactions regularly lead to homeostasis and maintenance of SC characteristics. However, the exact participation of each of these components for CSC maintenance is not clear, as they appear to be context- or cell-specific. In the recent past, surface cellular markers have been fundamental molecular tools for identifying CSC and distinguishing them from other tumor cells. Importantly, some of these cellular markers have been shown to possess functional roles that affect central aspects of CSC. Likewise, some of these markers can participate in regulating the interaction of CSC with their niche, particularly the ECM. We focused this review on the molecular mechanisms of surface cellular markers commonly employed to identify CSC, highlighting the signaling pathways and mechanisms involved in CSC-ECM interactions, through each of the cellular markers commonly used in the study of CSC, such as CD44, CD133, CD49f, CD24, CXCR4, and LGR5. Their presence does not necessarily implicate them in CSC biology. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Cancer; Extra Cellular Matrix (ECM); phenotype; self-renewal; signaling pathways; stemness; surface markers.

Year:  2019        PMID: 30147013     DOI: 10.2174/1574888X13666180821154752

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  1 in total

Review 1.  Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches.

Authors:  Eduardo Alvarado-Ortiz; Karen Griselda de la Cruz-López; Jared Becerril-Rico; Miguel Angel Sarabia-Sánchez; Elizabeth Ortiz-Sánchez; Alejandro García-Carrancá
Journal:  Front Cell Dev Biol       Date:  2021-02-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.